Soluble btnl2 protein useful to inhibit inflammatory disorders

Details Soluble btnl2 protein useful to inhibit inflammatory disorders Soluble btnl2 protein useful to inhibit inflammatory disorders

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61P 37/00 (2006.01)

Patent

CA 2602312

Described is a polypeptide-dimer comprising at least one soluble BTNL2 molecule, preferably two soluble BTNL2 molecules. In addition, a pharmaceutical composition is described containing said molecule and various medical uses of this molecule to inhibit T-cell mediated inflammatory disorders.

L'invention concerne un polypeptide-dimère comprenant au moins une molécule BTNL2 soluble, de préférence deux molécules BTNL2 solubles. De plus, l'invention concerne une composition pharmaceutique contenant ladite molécule ainsi que diverses utilisations médicales de cette molécule pour inhiber les troubles inflammatoires médiés par les lymphocytes T.

Affiliated with

Also associated with

Rating

Soluble btnl2 protein useful to inhibit inflammatory disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Soluble btnl2 protein useful to inhibit inflammatory disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble btnl2 protein useful to inhibit inflammatory disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1795726